Mounting evidence suggests that a more extensive surgical resection is associated with an improved life expectancy for both low-grade and high-grade glioma... Liu Jonathan T.C.,M Daphne,S Nader - 《Neurosurgery》 被引量: 49发表: 2014年 Advances in stem cell therapy against gliomas Malignant ...
Grade III tumours (also commonly referred to as anaplastic glioma) comprise anaplastic astrocytoma, mixed anaplastic oligoastrocytoma and anaplastic oligodendroglioma, while glioblastoma (GBM) represents WHO grade IV. Tissue diagnosis is mandatory, and usually obtained by stereotactic biopsy or after tumour...
Imaging characteristics of an unusual, high-grade angiocentric glioma: A case report and review of the literature Angiocentric gliomas have recently been reclassified as a separate central nervous system tumor. Few cases have been reported, and most of those correspond... HN Aguilar,RWY Hung,V ...
Introduction Patient reported outcome plays an increasingly important role in the evaluation of novel therapies for tumor patients. It has been shown that tumor treating fields (TTFields) in combination with standard therapy prolong survival in high-grade glioma (hgG) patients. But critics claim TTFiel...
High-grade glioma (HGG) is characterized by debilitating neurologic symptoms and poor prognosis. Some of the suffering this disease engenders may be ameliorated through palliative care, which improves quality of life for seriously ill patients by optimizing symptom management and psychosocial support, whi...
19. A kit for grading aggressiveness of high-grade glioma (HGG) and/or providing a HGG survival outcome to an individual, said kit comprising: reagents that specifically detect expression levels of the four genes, CHAF1B, PDLIM4, EDNRB and HJURP, or at least one reagent that specifically ...
diffuse midline glioma ews: ewing sarcomas hgg: high-grade gliomas hm: haematological malignancies id: immune desert ihc: immunohistochemistry ipass: immune paediatric signature score ir: immune rich mb: medulloblastomas mpnst: malignant peripheral nervous sheath tumour nbl: neuroblastoma nch: nationwide ...
(SCAN) Guidelines for Systemic Therapy of High-Grade Glioma The Singapore Cancer Network (SCAN) Neuro-Oncology Workgroup Abstract Introduction: The SCAN Neuro-Oncology workgroup aimed to develop Singapore Cancer Network (SCAN) clinical practice guidelines for systemic therapy for high-grade glioma in ...
In SCBT group, the brain tumor types included non-Neurofibromatosis-1 (NF1) (N = 31, 41.90%) and NF1-related low-grade glioma (N = 11, 14.90%), medulloblastoma (N = 16, 21.60%), germ cell tumors (N = 6, 8.10%), subependymal giant cell astrocytoma (N = ...
Chimeric antigen receptor T cell (CAR-T) therapy is an emerging strategy to improve treatment outcomes for recurrent high-grade glioma, a cancer that responds poorly to current therapies. Here we report a completed phase I trial evaluating IL-13Rα2-targ